New drug combo tested for tough-to-treat cancers
Disease control
Recruiting now
This study tests an experimental drug called TRK-950, alone or with another drug (nivolumab), in people with advanced solid tumors or melanoma that have not responded to standard treatments. The goal is to check safety, find the right dose, and see if the drug can shrink tumors. …
Phase: PHASE1, PHASE2 • Sponsor: Toray Industries, Inc • Aim: Disease control
Last updated May 17, 2026 02:01 UTC